## **Core Concept**
Scoline apnea, also known as succinylcholine-induced apnea, is a condition that occurs in certain individuals who are sensitive to the depolarizing muscle relaxant succinylcholine. This sensitivity is often due to a genetic variation affecting the enzyme plasma cholinesterase, which is responsible for metabolizing succinylcholine.

## **Why the Correct Answer is Right**
The correct answer, , is associated with a prolongation of apnea due to a deficiency or abnormality in plasma cholinesterase. This enzyme is crucial for the breakdown of succinylcholine. Individuals with atypical or deficient plasma cholinesterase cannot efficiently metabolize succinylcholine, leading to an extended duration of action of the drug and consequently prolonged apnea.

## **Why Each Wrong Option is Incorrect**
* **Option A:** - This option is incorrect because a normal homozygote ( ) would have normal plasma cholinesterase activity and would not experience prolonged apnea after succinylcholine administration.
* **Option B:** - This option is incorrect because a heterozygote ( ) would have some level of plasma cholinesterase activity, although reduced, and might experience a prolonged effect but not as severe as in homozygotes for the atypical gene.
* **Option D:** - This option is incorrect because it might suggest another genetic variation; however, without specific context, it's less directly related to the common understanding of scoline apnea.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that patients with a family history of prolonged apnea after succinylcholine administration should be tested for plasma cholinesterase activity and dibucaine number to determine their genotype and risk of prolonged apnea.

## **Correct Answer: .**